Identification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validation

Abstract Osteoarthritis (OA) is a degenerative bone disease characterized by the destruction of joint cartilage and synovial inflammation, involving intricate immune regulation processes. Disulfidptosis, a novel form of programmed cell death, has recently been identified; however, the effects and ro...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingjie Wei, Xiangwen Shi, Wenbao Tang, Qian Lv, Yipeng Wu, Yongqing Xu
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-85569-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544723672596480
author Mingjie Wei
Xiangwen Shi
Wenbao Tang
Qian Lv
Yipeng Wu
Yongqing Xu
author_facet Mingjie Wei
Xiangwen Shi
Wenbao Tang
Qian Lv
Yipeng Wu
Yongqing Xu
author_sort Mingjie Wei
collection DOAJ
description Abstract Osteoarthritis (OA) is a degenerative bone disease characterized by the destruction of joint cartilage and synovial inflammation, involving intricate immune regulation processes. Disulfidptosis, a novel form of programmed cell death, has recently been identified; however, the effects and roles of disulfidptosis-related genes (DR-DEGs) in OA remain unclear. We obtained six OA datasets from the GEO database, using four as training sets and two as validation sets. Differential expression analysis was employed to identify DR-DEGs, and unique molecular subtypes of OA were constructed based on these DR-DEGs. Subsequently, the immune microenvironment of OA patients was comprehensively analyzed using the “CIBERSORT” algorithm for immune infiltration. Various machine learning algorithms were utilized to screen characteristic DR-DEGs, and nomogram models and ROC curves were built based on these genes. The scRNA dataset (GSE169454) was used to classify chondrocytes in OA samples into distinct cell types, further exploring the gene distribution and correlation of characteristic DR-DEGs with specific cell subpopulations. Moreover, the expression levels of four characteristic DR-DEGs were validated through OA cell models and rat models. In our study, we identified 10 DR-DEGs with significant differences in expression within OA samples. Based on these DR-DEGs, two distinct molecular subtypes were recognized (cluster 1 and 2). ZNF484 and NDUFS1 were found to be significantly overexpressed in subtype 1, while the infiltration abundance of activated mast cells was markedly elevated in subtype 2. Moreover, significant differences were observed in the infiltration proportions of 11 immune cell types between OA and control samples, with 9 DR-DEGs demonstrating substantial correlations with immune cell infiltration levels. Further analysis of the scRNA dataset revealed that SLC3A2 and NDUFC1 were predominantly expressed in the preHTC subpopulation. All 10 DR-DEGs exhibited notably higher expression in the EC subpopulation across various cell types. The proportion of EC subgroups with high SLC3A2 expression increased, mainly enriching pathways related to inflammation, such as the IL-17 signaling pathway and TGF-beta signaling pathway. Using machine learning, we identified four characteristic DR-DEGs, which, in combination with the nomogram and ROC models, demonstrated promising performance in the diagnosis of OA. Additionally, in vivo validation confirmed a significant elevation of PPM1F expression in OA models. This study identified DR-DEGs as potential biomarkers for the diagnosis and classification of OA and provided a preliminary understanding of their role in the immune microenvironment. However, further experimental and clinical studies are required to validate their diagnostic value and therapeutic potential.
format Article
id doaj-art-2a84d55b93d245dc918c6e27ca0b94e1
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-2a84d55b93d245dc918c6e27ca0b94e12025-01-12T12:19:14ZengNature PortfolioScientific Reports2045-23222025-01-0115111910.1038/s41598-025-85569-zIdentification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validationMingjie Wei0Xiangwen Shi1Wenbao Tang2Qian Lv3Yipeng Wu4Yongqing Xu5Department of Orthopedic Surgery, 920th Hospital of Joint Logistics Support Force of PLADepartment of Orthopedic Surgery, 920th Hospital of Joint Logistics Support Force of PLADepartment of Orthopedic Surgery, 920th Hospital of Joint Logistics Support Force of PLADepartment of Orthopedic Surgery, 920th Hospital of Joint Logistics Support Force of PLADepartment of Orthopedic Surgery, 920th Hospital of Joint Logistics Support Force of PLADepartment of Orthopedic Surgery, 920th Hospital of Joint Logistics Support Force of PLAAbstract Osteoarthritis (OA) is a degenerative bone disease characterized by the destruction of joint cartilage and synovial inflammation, involving intricate immune regulation processes. Disulfidptosis, a novel form of programmed cell death, has recently been identified; however, the effects and roles of disulfidptosis-related genes (DR-DEGs) in OA remain unclear. We obtained six OA datasets from the GEO database, using four as training sets and two as validation sets. Differential expression analysis was employed to identify DR-DEGs, and unique molecular subtypes of OA were constructed based on these DR-DEGs. Subsequently, the immune microenvironment of OA patients was comprehensively analyzed using the “CIBERSORT” algorithm for immune infiltration. Various machine learning algorithms were utilized to screen characteristic DR-DEGs, and nomogram models and ROC curves were built based on these genes. The scRNA dataset (GSE169454) was used to classify chondrocytes in OA samples into distinct cell types, further exploring the gene distribution and correlation of characteristic DR-DEGs with specific cell subpopulations. Moreover, the expression levels of four characteristic DR-DEGs were validated through OA cell models and rat models. In our study, we identified 10 DR-DEGs with significant differences in expression within OA samples. Based on these DR-DEGs, two distinct molecular subtypes were recognized (cluster 1 and 2). ZNF484 and NDUFS1 were found to be significantly overexpressed in subtype 1, while the infiltration abundance of activated mast cells was markedly elevated in subtype 2. Moreover, significant differences were observed in the infiltration proportions of 11 immune cell types between OA and control samples, with 9 DR-DEGs demonstrating substantial correlations with immune cell infiltration levels. Further analysis of the scRNA dataset revealed that SLC3A2 and NDUFC1 were predominantly expressed in the preHTC subpopulation. All 10 DR-DEGs exhibited notably higher expression in the EC subpopulation across various cell types. The proportion of EC subgroups with high SLC3A2 expression increased, mainly enriching pathways related to inflammation, such as the IL-17 signaling pathway and TGF-beta signaling pathway. Using machine learning, we identified four characteristic DR-DEGs, which, in combination with the nomogram and ROC models, demonstrated promising performance in the diagnosis of OA. Additionally, in vivo validation confirmed a significant elevation of PPM1F expression in OA models. This study identified DR-DEGs as potential biomarkers for the diagnosis and classification of OA and provided a preliminary understanding of their role in the immune microenvironment. However, further experimental and clinical studies are required to validate their diagnostic value and therapeutic potential.https://doi.org/10.1038/s41598-025-85569-zOsteoarthritisDisulfidptosisChondrocyteSingle-cell sequencingDiagnosis
spellingShingle Mingjie Wei
Xiangwen Shi
Wenbao Tang
Qian Lv
Yipeng Wu
Yongqing Xu
Identification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validation
Scientific Reports
Osteoarthritis
Disulfidptosis
Chondrocyte
Single-cell sequencing
Diagnosis
title Identification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validation
title_full Identification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validation
title_fullStr Identification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validation
title_full_unstemmed Identification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validation
title_short Identification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validation
title_sort identification of a novel disulfidptosis related gene signature in osteoarthritis using bioinformatics analysis and experimental validation
topic Osteoarthritis
Disulfidptosis
Chondrocyte
Single-cell sequencing
Diagnosis
url https://doi.org/10.1038/s41598-025-85569-z
work_keys_str_mv AT mingjiewei identificationofanoveldisulfidptosisrelatedgenesignatureinosteoarthritisusingbioinformaticsanalysisandexperimentalvalidation
AT xiangwenshi identificationofanoveldisulfidptosisrelatedgenesignatureinosteoarthritisusingbioinformaticsanalysisandexperimentalvalidation
AT wenbaotang identificationofanoveldisulfidptosisrelatedgenesignatureinosteoarthritisusingbioinformaticsanalysisandexperimentalvalidation
AT qianlv identificationofanoveldisulfidptosisrelatedgenesignatureinosteoarthritisusingbioinformaticsanalysisandexperimentalvalidation
AT yipengwu identificationofanoveldisulfidptosisrelatedgenesignatureinosteoarthritisusingbioinformaticsanalysisandexperimentalvalidation
AT yongqingxu identificationofanoveldisulfidptosisrelatedgenesignatureinosteoarthritisusingbioinformaticsanalysisandexperimentalvalidation